Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tomer Israely and Yinon Levy.
Tomer Israely
Connection Strength
0.233
Yinon Levy
  1. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
    View in: PubMed
    Score: 0.060
  2. Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope. Viruses. 2021 03 26; 13(4).
    View in: PubMed
    Score: 0.059
  3. Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat Commun. 2021 02 11; 12(1):944.
    View in: PubMed
    Score: 0.058
  4. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.